Lifeward Ltd. Appoints Three Directors; Board Chair Named; Director Resigns

What Happened

• Lifeward Ltd. filed an 8-K reporting board changes: on August 14, 2026 the Board appointed Yonason Greenwald and Haggai Zamir as Class III directors; on August 20, 2026 the Board appointed Avraham Gabay as a Class III director and named him Chair of the Board. Each new director’s initial term expires at the Company’s 2026 Annual Meeting of Shareholders. Also on August 20, 2026, director Nadav Kidron resigned, effective immediately; his departure was not due to any disagreement with the Company.

Key Details

• Appointment dates: Yonason Greenwald and Haggai Zamir on August 14, 2026; Avraham Gabay on August 20, 2026.
• Committee memberships: Greenwald will serve on the Audit, Compensation and Nominating & Corporate Governance Committees; Zamir will serve on the Nominating & Corporate Governance Committee; Gabay will serve as Board Chair.
• Terms: All appointees are Class III directors with initial terms expiring at the 2026 Annual Meeting.
• Compensation and conflicts: Each new director will receive the Company’s standard non-employee director compensation as disclosed in Lifeward’s Form 10-K (filed March 18, 2026). No related-party transactions or family relationships requiring disclosure were reported.

Why It Matters

• Board composition and leadership changed quickly in August 2026, including a new Chair, which can affect corporate governance and oversight priorities.
• Committee assignments (especially Audit and Compensation) influence who oversees financial reporting and executive pay; investors may watch for any shifts in governance or strategy.
• The filing states the resignation was not due to disagreement and no related-party issues were disclosed, which limits immediate governance risk signals for shareholders.